These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31187785)

  • 61. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
    Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial.
    Bassiouny YA; Dakhly DMR; Bayoumi YA; Hashish NM
    Fertil Steril; 2016 Mar; 105(3):697-702. PubMed ID: 26690008
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist.
    Kummer N; Benadiva C; Feinn R; Mann J; Nulsen J; Engmann L
    Fertil Steril; 2011 Jul; 96(1):63-8. PubMed ID: 21565337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility.
    Foong SC; Fleetham JA; O'Keane JA; Scott SG; Tough SC; Greene CA
    J Assist Reprod Genet; 2006 Mar; 23(3):137-40. PubMed ID: 16622804
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
    Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
    J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved.
    Sfontouris IA; Kolibianakis EM; Lainas GT; Navaratnarajah R; Tarlatzis BC; Lainas TG
    J Assist Reprod Genet; 2015 May; 32(5):691-7. PubMed ID: 25758990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
    Fabris AM; Cruz M; Legidos V; Iglesias C; Muñoz M; García-Velasco JA
    Reprod Sci; 2017 Aug; 24(8):1221-1225. PubMed ID: 28715965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concomitant use of FSH and low-dose recombinant hCG during the late follicular phase versus conventional controlled ovarian stimulation for intracytoplasmic sperm injection cycles.
    Iaconelli CAR; Setti AS; Braga DPAF; Maldonado LGL; Iaconelli A; Borges E; Aoki T
    Hum Fertil (Camb); 2017 Dec; 20(4):285-292. PubMed ID: 28325095
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
    Zhang Z; Zhang XH; He TY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1170-4. PubMed ID: 26677665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.
    Zhou J; Wang B; Hu Y; Sun H
    Arch Gynecol Obstet; 2017 Nov; 296(5):1005-1012. PubMed ID: 28879481
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study.
    Westergaard LG; Erb K; Laursen SB; Rex S; Rasmussen PE
    Fertil Steril; 2001 Sep; 76(3):543-9. PubMed ID: 11532479
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.
    Balasch J; Creus M; Fábregues F; Civico S; Carmona F; Puerto B; Casamitjana R; Vanrell JA
    J Assist Reprod Genet; 2001 May; 18(5):250-6. PubMed ID: 11464575
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endometriosis and cumulative live birth rate after fresh and frozen IVF cycles with single embryo transfer in young women: no impact beyond reduced ovarian sensitivity-a case control study.
    Feichtinger M; Nordenhök E; Olofsson JI; Hadziosmanovic N; Rodriguez-Wallberg KA
    J Assist Reprod Genet; 2019 Aug; 36(8):1649-1656. PubMed ID: 31313013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.